Locations:
Search IconSearch

Provocative Testing & Coronary Artery Spasms

Provocative Ergonovine Testing Can Rule Out or Confirm the Diagnosis

Artery-690×380

When catheterization reveals normal coronary arteries in a patient complaining of angina, the tendency is to suspect a noncardiac condition. But if the patient continues to have angina, the diagnosis of coronary artery (CA) spasm should be considered.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

CA spasm producing angina in the absence of coronary artery disease (CAD) is a rare condition with certain characteristics that differentiate it from angina caused by ischemia. CA spasm angina predominantly occurs at rest, often awakening the patient at night or in the early morning. These episodes are transient, generally persisting for less than 15 minutes, and may cause syncope. Episodes can occur a few times yearly, a few times daily or infrequently.

The etiology of CA spasm is unknown. Most patients are aged 40 to 60. It is uncommon after age 70. Men and women are affected equally. In women, it may occur with menstruation. It is often associated with spasms in other arteries, causing conditions such as migraine or Reynaud’s syndrome.

Diagnostic dilemmas

Certain changes seen on EKG during an episode of spasm, most often ST elevation, can help make the diagnosis. The elevation generally resolves spontaneously in 10 to 15 minutes or in 1 to 2 minutes with nitroglycerin. Other patients may have ST-segment depression, ventricular tachycardia, ventricular fibrillation, complete heart block or asystole.

A Holter monitor makes it possible to capture some episodes of CA spasm. However, the quixotic nature of these spasms makes EKG documentation difficult to obtain.

Provocative testing

At Cleveland Clinic, we consider provocative ergonovine testing the definitive test for diagnosing this discreet syndrome. We have used it regularly 1972 and have found it to be effective in ruling out or confirming CA spasm. We consider the test safe: In our experience, no patient has died or developed a myocardial infarction during the test.

Advertisement

Ergonovine is a smooth muscle constrictor used primarily to stop postpartum bleeding. When given in the coronaries, ergonovine constricts the smooth muscle cells in the epithelium and triggers angina.

Provocative ergonomine testing is conducted in the cath lab. We first image the coronaries to ensure they are free of obstructive CAD. A bolus of ergonovine is then injected intravenously. Most patients will respond within 5 minutes. We take a complete EKG every minute, as changes in the EKG sometimes appear prior to angina. As soon as angina occurs, we reimage the coronaries. The patient is then given a syringe of premixed nitroglycerine or verapamil to reverse the spasm. The EKG should immediately normalize.

Less effective treatments

Numerous methods of testing for CA spasm have been tried over the years. Hyperventilation can trigger CA spasm, as can putting the patient’s hand in ice water for five minutes—an inhumane test that was popular in the 1970s. Neither was very sensitive, but occasionally worked.

Some institutions conduct provocative testing with acetocholine. However, this agent tends to elicit CA spasm in patients with CAD. We have seen patients who underwent provocative acetocholine testing and were diagnosed with CA spasm. When we repeated the test with ergonomine, the results were negative.

Stress testing is usually not helpful in making a diagnosis, unless the angina occurs with exertion. This scenario is the exception, rather than the rule.

Treating CA spasm

Once CA spasm is confirmed, calcium blockers can be used to control the spasms. A low dose is effective in some patients. Others require larger doses or even multiple calcium blockers.

Advertisement

Advertisement

Related Articles

female hands holding a pharmaceutical injector

GLP-1 RAs Show Survival and Cardiovascular Benefits in Patients With HFrEF and Diabetes

Large retrospective analysis may prompt prospective studies

doctor taking pulse of a woman in an exam room

Counseling Patients on the New Cholesterol Guideline: What Providers Should Know

How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more

stylized heart and lungs with text overlay

Highlights of Our Heart Failure and Electrophysiology Outcomes

A scannable recap of recent volumes and clinical metrics from Cleveland Clinic

map of the heart for use in cardiac ablation with catheter atop the map

Promising Early Experience With Dual-Energy Catheter Ablation of Ventricular Arrhythmias

Cleveland Clinic reports first U.S. series focused on use in this challenging setting

surgical team working at an operating table

Radical Pericardiectomy With Bypass Support Delivers the Best Outcomes in Constrictive Pericarditis

Large series confirms early and long-term survival advantages over partial pericardial resection

doctor looking at images on monitor during a heart procedure

Pulsed Field Ablation More Effective Than Medical Therapy for Initial Treatment of Persistent AF

AVANT GUARD trial extends first-line role for ablation beyond paroxysmal atrial fibrillation

woman on a bed grasping her chest in front of a doctor

AHA Statement Targets Gaps in ACS Care for Premenopausal Women

Maintain a high index of clinical suspicion and consider the underlying etiology

man lying on a gurney being rushed through a hospital

Standardizing STEMI Transfers: 4-Step Protocol Improves Care Processes and Survival

Protocol adoption at Cleveland Clinic sharply raised share of transferred patients getting timely PCI

Ad